Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-9.91	11.60	12.87
Graham Fair Price	-56.24	9045.12	20668.90
PEG	1182.75	-0.15	0.01
Price/Book	-1.94	0.60	0.61
Price/Cash Flow	90.50	-7.87	-82.80
Prices/Earnings	376.18	17.47	-3.67
Price/Sales	2.95	0.64	0.62
Price/FCF	90.50	-7.87	-82.80
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.65	0.63	0.57
Operating Margin	54.51	0.04	0.02
ROA	-79.67	< 0.005	< 0.005
ROE	-0.04	< 0.005	-79.41
ROIC	0.01	< 0.005	-29.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	-0.08	4.67
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.67	0.42	-37.81
EPS QOQ	-3.23	1.20	-62.88
FCF QOQ	-1.04	-8.94	-760.06
Revenue QOQ	-0.04	-0.08	-88.75
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	42.39	50.18	18.39
Days Sales Outstanding (DSO)	113.28	113.56	0.24
Inventory Turnover	2.12	1.79	-15.53
Debt/Capitalization	0.53	0.56	5.43
Quick Ratio	0.95	0.94	-0.87
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	21341.12	20580.48	-3.56
Cash	25339.98	25129.36	-0.83
Capex	-968.68	-1136.23	-17.30
Free Cash Flow	-157.72	-1569.75	-895.26
Revenue	21028.48	19314.60	-8.15
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.02	0.98	-4.01
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.49	5.44	-1.02
Naive Interpretation	Member

06 - Financial Health · Bad

Rating